Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSGlobe Newswire • 24 days ago
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch...
Share to Feed
This is a signal that SILK's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a signal that SILK's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that SILK's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a Bullish indicator signaling SILK's price could rise from here. Traders may explore going long the stock or buying call options...
This price move could be a signal that SILK may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling SILK's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
In recent trading, shares of Silk Road Medical Inc (SILK) have crossed above the average analyst 12-month target price of 16.75, changing hands for 16.99/share. When a stock reaches the...
Silk Road Medical, Inc (NASDAQ:SILK Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 29th, there was short interest...
Silk Road Medical, Inc (NASDAQ:SILK Get Free Report) CFO Lucas W. Buchanan sold 9,877 shares of the companys stock in a transaction dated Tuesday, March 5th. The shares were sold at an...